These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 16613692

  • 1. [Farnesyl transferase inhibitors--a novel agent for breast cancer].
    Zhang M, Jiang D.
    Ai Zheng; 2006 Apr; 25(4):516-20. PubMed ID: 16613692
    [Abstract] [Full Text] [Related]

  • 2. Farnesyl transferase inhibitors in the treatment of breast cancer.
    Kelland LR.
    Expert Opin Investig Drugs; 2003 Mar; 12(3):413-21. PubMed ID: 12605564
    [Abstract] [Full Text] [Related]

  • 3. Farnesyl transferase inhibitors: the next targeted therapies for breast cancer?
    O'Regan RM, Khuri FR.
    Endocr Relat Cancer; 2004 Jun; 11(2):191-205. PubMed ID: 15163298
    [Abstract] [Full Text] [Related]

  • 4. Farnesyl transferase inhibitors: a major breakthrough in anticancer therapy? Naples, 12 April 2002.
    Caponigro F.
    Anticancer Drugs; 2002 Sep; 13(8):891-7. PubMed ID: 12394276
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
    Lobell RB, Omer CA, Abrams MT, Bhimnathwala HG, Brucker MJ, Buser CA, Davide JP, deSolms SJ, Dinsmore CJ, Ellis-Hutchings MS, Kral AM, Liu D, Lumma WC, Machotka SV, Rands E, Williams TM, Graham SL, Hartman GD, Oliff AI, Heimbrook DC, Kohl NE.
    Cancer Res; 2001 Dec 15; 61(24):8758-68. PubMed ID: 11751396
    [Abstract] [Full Text] [Related]

  • 6. Farnesyl transferase inhibitors--a novel therapy for breast cancer.
    Johnston SR, Kelland LR.
    Endocr Relat Cancer; 2001 Sep 15; 8(3):227-35. PubMed ID: 11566614
    [Abstract] [Full Text] [Related]

  • 7. Inhibiting Ras signaling in the therapy of breast cancer.
    Li T, Sparano JA.
    Clin Breast Cancer; 2003 Feb 15; 3(6):405-16; discussion 417-20. PubMed ID: 12636885
    [Abstract] [Full Text] [Related]

  • 8. Farnesyltransferase inhibitors--a novel approach in the treatment of advanced pancreatic carcinomas.
    Dempke WC.
    Anticancer Res; 2003 Feb 15; 23(2A):813-8. PubMed ID: 12820305
    [Abstract] [Full Text] [Related]

  • 9. Farnesyltransferase inhibitors and their potential in the treatment of breast carcinoma.
    de Bono JS, Tolcher AW, Rowinsky EK.
    Semin Oncol; 2003 Oct 15; 30(5 Suppl 16):79-92. PubMed ID: 14613029
    [Abstract] [Full Text] [Related]

  • 10. The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity.
    Basso AD, Mirza A, Liu G, Long BJ, Bishop WR, Kirschmeier P.
    J Biol Chem; 2005 Sep 02; 280(35):31101-8. PubMed ID: 16006564
    [Abstract] [Full Text] [Related]

  • 11. Lipid posttranslational modifications. Farnesyl transferase inhibitors.
    Basso AD, Kirschmeier P, Bishop WR.
    J Lipid Res; 2006 Jan 02; 47(1):15-31. PubMed ID: 16278491
    [Abstract] [Full Text] [Related]

  • 12. [Farnesyltransferase inhibitors: preliminary results in acute myeloid leukemia].
    Thomas X, Elhamri M.
    Bull Cancer; 2005 Mar 02; 92(3):227-38. PubMed ID: 15820917
    [Abstract] [Full Text] [Related]

  • 13. [Development of farsenyl transferase inhibitors as anticancer agents].
    Cestac P, Doisneau-Sixou S, Favre G.
    Ann Pharm Fr; 2005 Jan 02; 63(1):76-84. PubMed ID: 15803104
    [Abstract] [Full Text] [Related]

  • 14. Preclinical and clinical evaluation of farnesyltransferase inhibitors.
    Baum C, Kirschmeier P.
    Curr Oncol Rep; 2003 Mar 02; 5(2):99-107. PubMed ID: 12583826
    [Abstract] [Full Text] [Related]

  • 15. Farnesyl transferase inhibitors as anticancer agents.
    Haluska P, Dy GK, Adjei AA.
    Eur J Cancer; 2002 Sep 02; 38(13):1685-700. PubMed ID: 12175684
    [Abstract] [Full Text] [Related]

  • 16. Clinical activity of farnesyl transferase inhibitors in hematologic malignancies: possible mechanisms of action.
    Jabbour E, Kantarjian H, Cortes J.
    Leuk Lymphoma; 2004 Nov 02; 45(11):2187-95. PubMed ID: 15512806
    [Abstract] [Full Text] [Related]

  • 17. Farnesyltransferase inhibitors.
    Hahn SM, Bernhard E, McKenna WG.
    Semin Oncol; 2001 Oct 02; 28(5 Suppl 16):86-93. PubMed ID: 11706400
    [Abstract] [Full Text] [Related]

  • 18. Perspectives on farnesyl transferase inhibitors in cancer therapy.
    Mazieres J, Pradines A, Favre G.
    Cancer Lett; 2004 Apr 08; 206(2):159-67. PubMed ID: 15013521
    [Abstract] [Full Text] [Related]

  • 19. Farnesyltransferase inhibitor as anticancer agent.
    Agrawal AG, Somani RR.
    Mini Rev Med Chem; 2009 Jun 08; 9(6):638-52. PubMed ID: 19519490
    [Abstract] [Full Text] [Related]

  • 20. Farnesyltransferase inhibitors in breast cancer therapy.
    Dy GK, Adjei AA.
    Cancer Invest; 2002 Jun 08; 20 Suppl 2():30-7. PubMed ID: 12442347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.